Central Nervous System Disease Associated with Major Viral Haemorrhagic Fever Viruses of Public Health Importance: Challenges in Patient Diagnosis, Evaluation, and Management in Resource-Limited Settings

Viral haemorrhagic fever (VHF) viruses cause infectious diseases that are of public health importance. Billions of people from all over the world are at risk of exposure to infection from these viruses with epidemics or outbreaks occurring in both endemic and non-endemic areas. The VHF viruses are largely neglected but are re-emerging as real threats to global health. While the more dramatic clinical presentations (such as bleeding and vascular collapse) are well known, the contribution of features that involve the central nervous system (CNS) to mortality and morbidity are not fully recognised. The diagnosis of VHF in febrile patients with CNS-related features, but who do not present with characteristic bleeding, may be missed or delayed because of a low index of suspicion. The proper evaluation of such patients with CNS disease is hampered by the dearth of neurologists and investigational tools, and weak health systems in resource-limited settings where most of the VHF viruses are endemic. Addressing these constraints would require investment in capacity building and infrastructural development in the affected countries.

[1]  Correction and Republication: Abortion Surveillance — United States, 2014 , 2018, MMWR. Morbidity and mortality weekly report.

[2]  P. Okokhere,et al.  Aseptic Meningitis Caused by Lassa Virus: Case Series Report , 2016, Case reports in neurological medicine.

[3]  J. Bordes,et al.  Ebola Virus-Related Encephalitis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Jing He,et al.  An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. , 2016, The Journal of infectious diseases.

[5]  G. Wilkie,et al.  Late Ebola virus relapse causing meningoencephalitis: a case report , 2016, The Lancet.

[6]  M. Lado,et al.  Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone , 2016, Emerging infectious diseases.

[7]  N. Wauquier,et al.  Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection , 2015, Journal of Virology.

[8]  Shirley C Nimo-Paintsil,et al.  Imported Lassa fever: a report of 2 cases in Ghana , 2015, BMC Infectious Diseases.

[9]  Tom Fletcher,et al.  Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. , 2015, The New England journal of medicine.

[10]  Pardis C Sabeti,et al.  Lassa Fever in Post-Conflict Sierra Leone , 2014, PLoS neglected tropical diseases.

[11]  P. Okokhere,et al.  Central nervous system manifestations of lassa fever in Nigeria and the effect on mortality , 2013, Journal of the Neurological Sciences.

[12]  C. Rosadas,et al.  Neurological complications in dengue infection: a review for clinical practice. , 2013, Arquivos de neuro-psiquiatria.

[13]  Joseph H. K. Bonney,et al.  The first cases of Lassa fever in Ghana. , 2012, Ghana medical journal.

[14]  Pardis C Sabeti,et al.  Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation , 2012, PLoS neglected tropical diseases.

[15]  R. Garg,et al.  Neurological complications of dengue fever: Experience from a tertiary center of north India , 2011, Annals of Indian Academy of Neurology.

[16]  D. Bausch,et al.  Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Nwegbu,et al.  Early-onset sensorineural hearing loss in Lassa fever , 2010, European Archives of Oto-Rhino-Laryngology.

[18]  P. Okokhere,et al.  The effect of malaria on the outcome of Lassa Fever , 2010 .

[19]  V. Gaware,et al.  Rift Valley Fever: a review. , 2010 .

[20]  S. Günther,et al.  Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands , 2009, Emerging infectious diseases.

[21]  P. Okokhere,et al.  Sensorineural hearing loss in Lassa fever: two case reports , 2009, Journal of medical case reports.

[22]  M. Wasay,et al.  Encephalitis and myelitis associated with dengue viral infection Clinical and neuroimaging features , 2008, Clinical Neurology and Neurosurgery.

[23]  U. Misra,et al.  Neurological manifestations of dengue virus infection , 2006, Journal of the Neurological Sciences.

[24]  K. Tyler,et al.  360 Meningitis , Encephalitis , Brain Abscess , and Empyema , 2005 .

[25]  A. Alrajhi,et al.  Rift Valley Fever Encephalitis , 2004, Emerging infectious diseases.

[26]  M. S. Merani,et al.  Epidemiology of argentine hemorrhagic fever , 1988, European Journal of Epidemiology.

[27]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[28]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[29]  S. Günther,et al.  Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. , 2001, The Journal of infectious diseases.

[30]  F. F. Busygin [Omsk hemorrhagic fever--current status of the problem]. , 2000, Voprosy virusologii.

[31]  C. Ramos,et al.  Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. , 1998, Journal of neurovirology.

[32]  L. Hutwagner,et al.  Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice , 1995, BMJ.

[33]  J. McCormick,et al.  Lassa fever encephalopathy: clinical and laboratory findings. , 1992, The Journal of tropical medicine and hygiene.

[34]  F. Byl,et al.  Audiometric Comparison of Lassa Fever Hearing Loss and Idiopathic Sudden Hearing Loss: Evidence for Viral Cause , 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[35]  J. McCormick,et al.  Acute sensorineural deafness in Lassa fever. , 1990, JAMA.

[36]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[37]  D. Simpson,et al.  Congo/Crimean haemorrhagic fever in Iraq. , 1981, Bulletin of the World Health Organization.

[38]  J. Maiztegui,et al.  EFFICACY OF IMMUNE PLASMA IN TREATMENT OF ARGENTINE HÆMORRHAGIC FEVER AND ASSOCIATION BETWEEN TREATMENT AND A LATE NEUROLOGICAL SYNDROME , 1979, The Lancet.

[39]  D. Simpson Viral haemorrhagic fevers of man. , 1979, WHO chronicle.

[40]  T. Bothwell,et al.  Outbreake of Marburg virus disease in Johannesburg. , 1975, British medical journal.

[41]  O. Tomori,et al.  Lassa fever in Onitsha, East Central State, Nigeria in 1974. , 1975, Bulletin of the World Health Organization.

[42]  D. Monteverde,et al.  [Neurological study of 120 cases of Argentine hemorrhagic fever]. , 1969, Prensa medica argentina.

[43]  A. Trejos,et al.  Clinical pathology of yellow fever. , 1955, American journal of clinical pathology.